C. rosea, a filamentous fungus recognized for its biocontrol potential, employs diverse mechanisms to combat F. oxysporum. It competes with the pathogen for nutrients and space, thereby impeding its colonization in plant roots (Lopez-Diaz et al., 2017). Additionally, C. rosea produces a range of secondary metabolites such as gliotoxin and clonorosein, along with volatile organic compounds like 6-pentyl-α-pyrone, which exhibit potent antifungal properties by disrupting fungal cell membranes and inducing oxidative stress (Wu et al., 2018). These metabolites not only directly inhibit F. oxysporum's growth and spore germination but also induce systemic resistance in plants, enhancing their defense responses against fungal infections (Hansson et al., 2012). Such multifaceted mechanisms highlight C. rosea's potential as a sustainable alternative to chemical fungicides in agriculture. In response to the escalating threat of drug-resistant fungal pathogens, our study focused on exploring the antagonistic potential of C. rosea against F. oxysporum through metabolite analysis, complemented by molecular docking analysis to elucidate its mechanisms in disease prevention.
Through morphological and DNA analysis via ITS sequencing, we identified F. oxysporum,F. equiseti, and F. brachygibbosum in ridge gourd plants, confirming their pathogenicity. All tested isolates exhibited typical morphological features of pathogenic Fusarium species (Edel-Hermann and LeComte, 2019). Pathogenicity tests specifically highlighted formae speciales of F. oxysporum as the primary agents responsible for wilt in luffa plants, whereas, other two species were only occasional or minor threats. These results underscore the variable pathogenic potentials of different Fusarium species affecting luffa, emphasizing the necessity for targeted approaches in disease management. These findings align with previous research documenting the diverse pathogenic behaviors of Fusarium species across cucurbit plants (Chehri et al., 2011; Renteria-Martinez et al., 2015; Asma et al., 2018; Bindal et al., 2023). Our findings illustrate that C. rosea effectively inhibits Fusarium spp., achieving inhibition rates ranging from 31.87% to 71.59%, depending on the specific methods employed. Previous studies have also highlighted the antagonistic capabilities of Clonostachys species against Fusarium spp. For instance, strains like UDC-222 and C. rosea have shown inhibition of up to 23% against F. circinatum and 65% against F. oxysporum hyphae in vitro (Moraga-suazo et al., 2011; Mahmoud, 2016). Other strains of Clonostachys have demonstrated significant inhibition against various Fusarium pathogens, indicating their broad potential for biocontrol (Bahadoor et al., 2023; Belingheri et al., 2024).
Microscopic examination in our study confirmed the mycoparasitic behavior of C. rosea against Fusarium mycelia, involving coiling around and penetrating their cell walls. This dual action suggests a combination of mechanical and enzymatic activities leading to the disintegration of pathogen mycelia, demonstrating effective hyphal parasitism. Consistent with previous research, C. rosea has been recognized for its mycoparasitic capabilities in combating Fusarium species (Chtterton and Punja, 2009; Tian et al., 2014; Karlsson et al., 2015). The gene expression studies further emphasize the crucial role of secondary metabolites in facilitating these mycoparasitic interactions (Nygren et al., 2018). Consequently, we identified secondary metabolites responsible for the antifungal activity, highlighting the multifaceted mechanisms employed by C. rosea in combatting fungal pathogens.
The metabolite analysis aimed to elucidate the biochemical pathways and interactions underlying C. rosea's antagonistic activity against F. oxysporum. From C. rosea, 44 biomolecules were identified, with 24 showing high retention area and peak area percentage. These metabolites span diverse chemical classes, including fatty acids, alcohols, amines, thiols, triazoles, indoline, steroids, and hydrazines, known for their wide-ranging bioactive properties such as antimicrobial, insecticidal, antioxidant, antifungal, and anti-inflammatory effects. Key compounds, such as cis-vaccenic acid, cis-9-hexadecenoic acid, and eicosapentaenoic acid (fatty acids); 1-dodecanol, 2-nonanol, and 1-hexadecanol (alcohols); 2-nonadecanone 2,4-dinitrophenylhydrazine (hydrazines); tert-hexadecanthiol (amines), exhibit potent antimicrobial and antifungal activities against Fusarium species (Jeeva and Krishnamoorthy, 2018; Khan et al., 2018; Ponnuswamy et al., 2018; Zhao et al., 2019; Sama et al., 2021; Oviya et al., 2022). Moreover, cis-vaccenic acid and 9,12-octadecadienoic acid have been found to exhibit antimicrobial properties against various pathogens (Hamlal and Subban, 2012). Notably, Compounds with 1,2,4-triazole and tertiary amine moieties have demonstrated antifungal activity against various pathogens (Sui et al., 2017). Amines and their derivatives disrupt fungal hyphae, reduce mycelial growth, and restrict spore germination and germ tube elongation, thereby effectively combating phytopathogenic fungi (Hueck et al., 1966). Recent studies have also highlighted the antimicrobial activity of volatile amine derivatives against key fungal pathogens (Chobe et al., 2014). Indole compounds play a crucial role in plant defense and act as antifungal agents against necrotrophic pathogens sucha s Fusarium spp. (Shen et al., 2018; Angarita-Rodriguez et al., 2019). Collectively, these bioactive compounds from various classes likely contribute to inhibiting the growth of F. oxysporum. Our metabolite profiling of C. rosea extracts provides insights into their antifungal effects, setting the stage for further investigations into their specific roles and mechanisms. This research holds promise for developing innovative strategies to combat fungal drug resistance effectively.
Computational modeling, particularly molecular docking approaches, offers valuable insights into the mechanisms of antifungal molecules that hinder fungal infection processes. By predicting the binding of molecules to protein active sites critical for fungal infection, these methods aid in identifying potential antifungal agents and comprehending their modes of action at a molecular level. This approach enables researchers to screen and prioritize compounds based on their ability to interact with specific fungal proteins involved in virulence and pathogenicity, thereby facilitating the development of targeted antifungal therapies (Toubi et al., 2019). In this study, molecular docking was employed to assess the binding interactions between active molecules derived from C. rosea extracts with six key proteins of F. oxysporum. The results highlighted that compounds such as 1-hexadecanol, 4-trifluoroacetoxytetradecane,2-nonadecanone, 2,4-dinitrophenylhydrazine, cis-13-eicosenoic acid, cis-vaccenic acid, and 2-nonanol bound with these F. oxysporum proteins, which play pivotal roles in various cellular processes controlling fungal virulence. Studies have underscored the significance of specific pathogenicity proteins like Succinate dehydrogenase, eubricol 14-alpha-demethylase, b-tubulin, E3 ubiquitin-protein ligase, DASH complex subunit, and acetolactate synthase in fungal pathogenesis and their potential as targets for disease control (Kersher et al., 2006; Chatterji et al., 2011; Fan et al., 2013; Zhang et al., 2019; Shao et al., 2022; Song et al., 2021). These findings are consistent with previous research utilizing molecular docking to elucidate the antifungal mechanisms of various compounds against fungal proteins (Rampersad et al., 2020). Recent studies have also highlighted the role of hydrogen bonds and hydrophobic interactions in the interaction of diacylhydrazine compounds with Succinate dehydrogenase, suggesting phenol and diacylhydrazine moieties as potential pharmacophores for bioactivity (Zhao et al., 2021).
Our findings contribute to the understanding of the multifaceted mechanisms employed by C. rosea in combating fungal pathogens, paving the way for innovative approaches to overcoming fungal drug resistance. Future research should focus on the specific roles and mechanisms of these bioactive compounds and validate them through in vitro and in vivo studies, as well as RT-PCR techniques. This comprehensive approach could potentially lead to the development of new antifungal agents and sustainable disease management strategies in agriculture.